Norvasc and Oramorph sr drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Norvasc (amlodipine besylate) and Oramorph sr (morphine sulfate). Common drug interactions include dyspnoea among females and hypotension among males.

The phase IV clinical study analyzes what interactions people have when they take Norvasc and Oramorph sr. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Norvasc?

Norvasc has active ingredients of amlodipine besylate. It is often used in high blood pressure. eHealthMe is studying from 136,738 Norvasc users. Check the latest studies of Norvasc.

What is Oramorph sr?

Oramorph sr has active ingredients of morphine sulfate. It is often used in pain. eHealthMe is studying from 2,897 Oramorph sr users. Check the latest studies of Oramorph sr.

On Aug, 02, 2026

19 people who take Norvasc and Oramorph sr together, and have interactions are studied.

Norvasc and Oramorph sr drug interactions.

What are the common drug interactions of Norvasc and Oramorph Sr, by gender? *:

female:

Dyspnoea (difficult or laboured respiration)
Chest pain
Abdominal pain upper
Cardiac failure congestive
Fatigue (feeling of tiredness)
Hypoxia (low oxygen in tissues)
Malaise (a feeling of general discomfort or uneasiness)
Pneumonia
Agitation (state of anxiety or nervous excitement)
Arteriosclerosis (thickening and hardening of arteries)

male:

Hypotension (abnormally low blood pressure)
Acetabulum fracture (socket of the hip joint- fracture)
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs)
Fatigue (feeling of tiredness)
Hallucination (an experience involving the perception of something not present)
Heart rate increased
Hypoxia (low oxygen in tissues)
Infection
Oedema lower limb (fluid collection in tissue of lower leg)
Pneumonia

What are the common drug interactions of Norvasc and Oramorph Sr, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Dyspnoea (difficult or laboured respiration)
Chest pain
Cardiac failure congestive
Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
Fatigue (feeling of tiredness)
Malaise (a feeling of general discomfort or uneasiness)
Weakness

50-59:

Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Chest pain

60+:

Hypoxia (low oxygen in tissues)
Pneumonia
Anaemia (lack of blood)
Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
Arteriosclerosis (thickening and hardening of arteries)
Asthenia (weakness)
Asthma
Atelectasis (partial or complete collapse of the lung)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Atrioventricular block first degree (heart block first degree)

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 5.26%
Non-Small Cell Lung Cancer Metastatic (type of epithelial lung cancer spreads to other parts): 1 person, 5.26%
Multiple Myeloma (cancer of the plasma cells): 1 person, 5.26%
Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 1 person, 5.26%
Metastases To Bone (cancer spreads to bone): 1 person, 5.26%
Lung Neoplasm Malignant (cancer tumour of lung): 1 person, 5.26%
Lung Cancer Metastatic (lung cancer spreads to other parts): 1 person, 5.26%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 5.26%
Chest Pain: 1 person, 5.26%
Back Pain: 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Norvasc and Oramorph sr?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously